281 related articles for article (PubMed ID: 15455280)
21. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease].
Gisbert JP; Gomollón F; Maté J; Pajares JM
Gastroenterol Hepatol; 2002; 25(6):401-15. PubMed ID: 12069704
[No Abstract] [Full Text] [Related]
22. [Azathioprine in inflammatory bowel disease].
Leite S; Ribeiro JM; Lima SC; Barroso S; Cotter J
Acta Med Port; 2009; 22(1):33-40. PubMed ID: 19341591
[TBL] [Abstract][Full Text] [Related]
23. [Maintaining a remission].
Fleig WE;
Z Gastroenterol; 2003 Jan; 41(1):36-42. PubMed ID: 12541172
[No Abstract] [Full Text] [Related]
24. [Role of thiopurine agents in ulcerative colitis].
Chaparro M; Gisbert JP
Gastroenterol Hepatol; 2011 Dec; 34 Suppl 3():30-5. PubMed ID: 25443224
[TBL] [Abstract][Full Text] [Related]
25. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
Sandborn WJ
Am J Gastroenterol; 1996 Mar; 91(3):423-33. PubMed ID: 8633486
[No Abstract] [Full Text] [Related]
26. Standard immunosuppression in IBD: current practice.
Feagan BG
Acta Gastroenterol Belg; 2001; 64(2):182-8. PubMed ID: 11475131
[No Abstract] [Full Text] [Related]
27. [Efficacy and safety of cyclosporine in the treatment of inflammatory bowel disease in children - a retrospective study].
Socha P; Wawer Z; Ryzko J; Orłowska E; Szczepański M; Kierkus J; Celińska-Cedro D; Socha J
Med Wieku Rozwoj; 2006; 10(2):429-35. PubMed ID: 16825713
[TBL] [Abstract][Full Text] [Related]
28. [Chronically active Crohn's disease].
Hoffmann J; Zeitz M;
Z Gastroenterol; 2003 Jan; 41(1):31-5. PubMed ID: 12541171
[No Abstract] [Full Text] [Related]
29. Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
Soh JS; Yun WJ; Kim KJ; Won CH; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
Inflamm Bowel Dis; 2015 Apr; 21(4):832-9. PubMed ID: 25789922
[TBL] [Abstract][Full Text] [Related]
30. [Ulcerative colitis. Maintenance therapy].
Kruis W; Schreiber S
Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
[No Abstract] [Full Text] [Related]
31. Efficacy of conventional immunosuppressive drugs in IBD.
Caprilli R; Angelucci E; Cocco A; Viscido A; Zippi M
Dig Liver Dis; 2004 Nov; 36(11):766-80. PubMed ID: 15571009
[TBL] [Abstract][Full Text] [Related]
32. Increased dosing requirements for 6-mercaptopurine and azathioprine in inflammatory bowel disease patients six years and younger.
Grossman AB; Noble AJ; Mamula P; Baldassano RN
Inflamm Bowel Dis; 2008 Jun; 14(6):750-5. PubMed ID: 18266236
[TBL] [Abstract][Full Text] [Related]
33. Next steps on the thiopurine methyltransferase 6-thioguanine nucleotide pathway.
Colletti RB
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):282-3. PubMed ID: 16954947
[No Abstract] [Full Text] [Related]
34. Azathioprine: an update on clinical efficacy and safety in inflammatory bowel disease.
Lamers CB; Griffioen G; van Hogezand RA; Veenendaal RA
Scand J Gastroenterol Suppl; 1999; 230():111-5. PubMed ID: 10499471
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
[TBL] [Abstract][Full Text] [Related]
36. Experience with the use of low-dose methotrexate for inflammatory bowel disease.
Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD
Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease.
Tajiri H; Tomomasa T; Yoden A; Konno M; Sasaki M; Maisawa S; Sumazaki R; Shimizu T; Toyoda S; Etani Y; Nakacho M; Ushijima K; Kobayashi A;
Digestion; 2008; 77(3-4):150-4. PubMed ID: 18577852
[TBL] [Abstract][Full Text] [Related]
38. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
[TBL] [Abstract][Full Text] [Related]
39. Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease.
Vandell AG; DiPiro JT
Pharmacotherapy; 2002 May; 22(5):613-20. PubMed ID: 12013360
[TBL] [Abstract][Full Text] [Related]
40. Ulcerative colitis: conservative management and long-term effects.
Kühbacher T; Schreiber S; Fölsch UR
Langenbecks Arch Surg; 2004 Oct; 389(5):350-3. PubMed ID: 15133672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
